Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

Launched by CHINESE UNIVERSITY OF HONG KONG · Oct 29, 2020

Keywords

ClinConnect Summary

This clinical trial is studying how COVID-19 affects lung function, exercise ability, and overall quality of life in patients over a period of two years. The researchers want to understand how long the body’s immune response to the virus lasts and how effective different COVID-19 vaccines are at providing protection. They will also look into whether a third booster shot can help those who didn’t develop enough antibodies after receiving two doses of a specific vaccine (CoronaVac).

To participate in this study, you must have been discharged from the hospital after treatment for COVID-19 and be between the ages of 65 and 74. Participants will undergo assessments to measure lung function and exercise capacity, and they will be followed for several months to see how their health changes over time. If you’re interested in helping researchers learn more about the long-term effects of COVID-19, this trial might be a good opportunity for you.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: Patients who have been discharged from hospital following treatment for COVID-19 -
• • Exclusion Criteria: Unwilling to be follow up
• • -